Femacare’s non-hormonal IUD leverages electro-spun technology to deliver active pharmaceutical agents effectively, ensuring both contraception and protection against STIs, including HIV. The device is female-controlled, discreet, fully reversible, and cost-effective, designed to provide widespread accessibility while improving maternal outcomes and reducing mortality rates in underserved regions.